1	Aumentar	aumentar	VMN0000	-	-	0-8	730(1)_ANS_clinical_caseMIR	SENT1	-	-
2	:	:	Fd	-	-	8-9	730(1)_ANS_clinical_caseMIR	SENT1	-	-
3	incrementar	incrementar	VMN0000	-	-	10-21	730(1)_ANS_clinical_caseMIR	SENT1	-	-
4	la	el	DA0FS0	-	-	22-24	730(1)_ANS_clinical_caseMIR	SENT1	-	-
5	percepción	percepción	NCFS000	C0030971	entidad_observable	25-35	730(1)_ANS_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0332285	atributo	36-38	730(1)_ANS_clinical_caseMIR	SENT1	-	-
7	riesgo	riesgo	NCMS000	-	-	39-45	730(1)_ANS_clinical_caseMIR	SENT1	-	-
8	para	para	SPS00	C0521125	calificador	46-50	730(1)_ANS_clinical_caseMIR	SENT1	-	-
9	facilitar	facilitar	VMN0000	-	-	51-60	730(1)_ANS_clinical_caseMIR	SENT1	-	-
10	el	el	DA0MS0	C0025320_1	entidad_observable_1	61-63	730(1)_ANS_clinical_caseMIR	SENT1	-	-
11	cambio	cambio	NCMS000	C0025320_2	entidad_observable_2	64-70	730(1)_ANS_clinical_caseMIR	SENT1	-	-
12	(	(	Fpa	-	-	71-72	730(1)_ANS_clinical_caseMIR	SENT1	-	-
13	explicar	explicar	VMN0000	-	-	72-80	730(1)_ANS_clinical_caseMIR	SENT1	-	-
14	las	el	DA0FP0	-	-	81-84	730(1)_ANS_clinical_caseMIR	SENT1	-	-
15	consecuencias	consecuencia	NCFP000	C0543419#C1368999#C1704419#C1280500#C1280519	hallazgo	85-98	730(1)_ANS_clinical_caseMIR	SENT1	-	-
16	del	del	SP+DA	-	-	99-102	730(1)_ANS_clinical_caseMIR	SENT1	-	-
17	tabaquismo	tabaquismo	NCMS000	C0040332#C0040336#C1306274#C0425291_1	trastorno#entidad_observable_1	103-113	730(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
18	)	)	Fpt	-	-	113-114	730(1)_ANS_clinical_caseMIR	SENT1	-	-
19	.	.	Fp	-	-	114-115	730(1)_ANS_clinical_caseMIR	SENT1	-	-

